Global Pharma Cm S.A.

Manufacture of food supplements

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-03-05
Share capital
110,000.00 PLN
Activity description

Global Pharma Cm is a contract manufacturer of dietary supplements and medical products, offering production in various forms such as softgels, tablets, syrups, and sprays. The company collaborates with partners from Poland and abroad, adhering to ISO 22000 and ISO 13485 standards. Their services include personalized product development and support throughout the production process, from ingredient selection to final documentation.

Registered address
ul. Berezów 49A, 26-130 Suchedniów, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-25643-39786-CTVBE-23

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$704,394

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 60 days late). 5 of 6 audited by a statutory auditor.

  • 202512/06/2026
  • 202427/06/2025
  • 202302/07/2024
  • 202226/05/2023
  • 202113/09/2022
  • 202002/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 8.3%
Division · Manufacture of food products520 / 3,403
Top 15%
Sector · Manufacturing2,363 / 24,548
Top 9.6%
City · Suchedniów2 / 38
Top 5.3%
Voivodeship · Świętokrzyskie151 / 4,913
Top 3.1%
Country · Poland9,128 / 297,069
Top 3.1%

Results vs industry

Revenue
This companyUSD 24.13mMedianUSD 284.01kAverageUSD 6.97m
Net profit
This companyUSD 3.14mMedianUSD 4.93kAverageUSD 683.78k
Operating costs
This companyUSD 19.03mMedianUSD 387.31kAverageUSD 6.05m
Assets
This companyUSD 18.27mMedianUSD 349.52kAverageUSD 6.87m

Offer

Certifications: GMP, ISO 13485, ISO 22000

Websites

The site is available in: Polish and English.

  • globalpharma.plProdukcja kontraktowa suplementów diety – Global Pharma CM
    WordPress 3.15Google Tag ManagerYoast SEOPolylangLiteSpeed

Authorized Representatives

Aleksandra Wiesława Puskarz-Kusa age 56 – Attorney-in-fact (joint)
Andrzej Bronisław Zieliński age 52 – Attorney-in-fact (joint)
Dorota Katarzyna Kruszewska age 53 – Attorney-in-fact (joint)
Marzena Siemińska age 57 – Vice President of the Management Board
Tomasz Nawrocki age 46 – President of the Management Board

Manner of representation

In the event of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company and to represent the company, provided that the President of the Management Board and the Vice-President of the Management Board are authorized to make declarations of will on behalf of the company independently and to represent the company independently.

Supervisory board

Marcin Andrzej Gajewski age 49 – Supervisory Board Member
Tomasz Artur Grendysz age 49 – Supervisory Board Member
Krzysztof Robert Miszewski age 53 – Supervisory Board Member

Ownership

Owner
Neuca S.A.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-05-16.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$60,545
Buildings and premises
$3.1M

Public aid

12 public aid cases recorded, with a total value of $647,783.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Regional investment aid
–

European Funds

4 projects co-financed from European Funds recorded, with total EU co-financing of $457,278.

ProjectEU co-financing
Implementation of innovative technology for the production of dietary supplements at GLOBAL PHARMA CM SP. Z O. O.
$214.8K
Promotion of the Global Pharma Contract Manufacturing product brand in international markets in 2021-2022.
$33,912
Promotion of the Global Pharma product brand on international markets in 2019-2020
$79,125

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Prosuplement Group sp. z o.o.
Curtis Health Caps S.A.
Efferta Pharma sp. z o.o.
Exim Pharma sp. z o.o.
Master Pharm S.A.
Symbiofarm Krok sp. k.
Europharma Alliance sp. z o.o.
Ośrodek Badawczo-Produkcyjny Politechniki Łódzkiej Ichem sp. z o.o.
Stella Nutrition sp. z o.o.
Tantus sp. z o.o.

Change history

DateEvent
2025-07-24Switch to PKD 2025
2022-11-21PKD change
2022-04-14Share capital increase
2021-03-05Entered in the register

FAQ

Last updated: 2026-10-19